P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY

Detalles Bibliográficos
Autores principales: Askeland, F. B., Haukås, E., Slørdahl, T. S., Schjøll, D., Lysen, A., Hermansen, E., Schjesvold, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429601/
http://dx.doi.org/10.1097/01.HS9.0000846428.64094.91
_version_ 1784779505766760448
author Askeland, F. B.
Haukås, E.
Slørdahl, T. S.
Schjøll, D.
Lysen, A.
Hermansen, E.
Schjesvold, F.
author_facet Askeland, F. B.
Haukås, E.
Slørdahl, T. S.
Schjøll, D.
Lysen, A.
Hermansen, E.
Schjesvold, F.
author_sort Askeland, F. B.
collection PubMed
description
format Online
Article
Text
id pubmed-9429601
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94296012022-08-31 P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY Askeland, F. B. Haukås, E. Slørdahl, T. S. Schjøll, D. Lysen, A. Hermansen, E. Schjesvold, F. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429601/ http://dx.doi.org/10.1097/01.HS9.0000846428.64094.91 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Askeland, F. B.
Haukås, E.
Slørdahl, T. S.
Schjøll, D.
Lysen, A.
Hermansen, E.
Schjesvold, F.
P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY
title P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY
title_full P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY
title_fullStr P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY
title_full_unstemmed P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY
title_short P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY
title_sort p888: replacing steroids in transplant-ineligible multiple myeloma: the phase 2 isatuximab-bortezomib-lenalidomide-dexamethasone rest study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429601/
http://dx.doi.org/10.1097/01.HS9.0000846428.64094.91
work_keys_str_mv AT askelandfb p888replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy
AT haukase p888replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy
AT slørdahlts p888replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy
AT schjølld p888replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy
AT lysena p888replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy
AT hermansene p888replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy
AT schjesvoldf p888replacingsteroidsintransplantineligiblemultiplemyelomathephase2isatuximabbortezomiblenalidomidedexamethasonereststudy

Ejemplares similares